Molecular Components and Functions of the Endocannabinoid System in Mouse Prefrontal Cortex

Background Cannabinoids have deleterious effects on prefrontal cortex (PFC)-mediated functions and multiple evidences link the endogenous cannabinoid (endocannabinoid) system, cannabis use and schizophrenia, a disease in which PFC functions are altered. Nonetheless, the molecular composition and the physiological functions of the endocannabinoid system in the PFC are unknown. Methodology/Principal Findings Here, using electron microscopy we found that key proteins involved in endocannabinoid signaling are expressed in layers V/VI of the mouse prelimbic area of the PFC: presynaptic cannabinoid CB1 receptors (CB1R) faced postsynaptic mGluR5 while diacylglycerol lipase α (DGL-α), the enzyme generating the endocannabinoid 2-arachidonoyl-glycerol (2-AG) was expressed in the same dendritic processes as mGluR5. Activation of presynaptic CB1R strongly inhibited evoked excitatory post-synaptic currents. Prolonged synaptic stimulation at 10Hz induced a profound long-term depression (LTD) of layers V/VI excitatory inputs. The endocannabinoid -LTD was presynaptically expressed and depended on the activation of postsynaptic mGluR5, phospholipase C and a rise in postsynaptic Ca2+ as predicted from the localization of the different components of the endocannabinoid system. Blocking the degradation of 2-AG (with URB 602) but not of anandamide (with URB 597) converted subthreshold tetanus to LTD-inducing ones. Moreover, inhibiting the synthesis of 2-AG with Tetrahydrolipstatin, blocked endocannabinoid-mediated LTD. All together, our data show that 2-AG mediates LTD at these synapses. Conclusions/Significance Our data show that the endocannabinoid -retrograde signaling plays a prominent role in long-term synaptic plasticity at the excitatory synapses of the PFC. Alterations of endocannabinoid -mediated synaptic plasticity may participate to the etiology of PFC-related pathologies.

[1]  D. Lovinger,et al.  Induction of striatal long‐term synaptic depression by moderate frequency activation of cortical afferents in rat , 2005, The Journal of physiology.

[2]  M. Kano,et al.  Presynaptic Monoacylglycerol Lipase Activity Determines Basal Endocannabinoid Tone and Terminates Retrograde Endocannabinoid Signaling in the Hippocampus , 2007, The Journal of Neuroscience.

[3]  T. Sejnowski,et al.  Synaptic background noise controls the input/output characteristics of single cells in an in vitro model of in vivo activity , 2003, Neuroscience.

[4]  P. Janak,et al.  Neuronal and behavioral correlations in the medial prefrontal cortex and nucleus accumbens during cocaine self-administration by rats , 2000, Neuroscience.

[5]  David Robbe,et al.  Presynaptic Homeostatic Plasticity Rescues Long-Term Depression after Chronic Δ9-Tetrahydrocannabinol Exposure , 2005, The Journal of Neuroscience.

[6]  Anatol C. Kreitzer,et al.  Dopamine Modulation of State-Dependent Endocannabinoid Release and Long-Term Depression in the Striatum , 2005, The Journal of Neuroscience.

[7]  David Robbe,et al.  Localization and Mechanisms of Action of Cannabinoid Receptors at the Glutamatergic Synapses of the Mouse Nucleus Accumbens , 2001, The Journal of Neuroscience.

[8]  L. Petrocellis,et al.  Endocannabinoid signalling in the blood of patients with schizophrenia , 2003, Lipids in Health and Disease.

[9]  H Ujike,et al.  CNR1, central cannabinoid receptor gene, associated with susceptibility to hebephrenic schizophrenia , 2002, Molecular Psychiatry.

[10]  H. Ujike,et al.  New perspectives in the studies on endocannabinoid and cannabis: cannabinoid receptors and schizophrenia. , 2004, Journal of pharmacological sciences.

[11]  J. Coyle,et al.  Glutamatergic mechanisms in schizophrenia. , 2003, Annual review of pharmacology and toxicology.

[12]  N. Griffon,et al.  Schizophrenia and the cannabinoid receptor type 1 (CB1): association study using a single-base polymorphism in coding exon 1. , 2001, American journal of medical genetics.

[13]  A. Hoffman,et al.  Functional Tolerance and Blockade of Long-Term Depression at Synapses in the Nucleus Accumbens after Chronic Cannabinoid Exposure , 2003, The Journal of Neuroscience.

[14]  M. Pistis,et al.  Prefrontal Cortex Stimulation Induces 2-Arachidonoyl-Glycerol-Mediated Suppression of Excitation in Dopamine Neurons , 2004, The Journal of Neuroscience.

[15]  T. Freund,et al.  Role of endogenous cannabinoids in synaptic signaling. , 2003, Physiological reviews.

[16]  P. Pacher,et al.  The Endocannabinoid System as an Emerging Target of Pharmacotherapy , 2006, Pharmacological Reviews.

[17]  P. Goldman-Rakic Cellular basis of working memory , 1995, Neuron.

[18]  A. Grace,et al.  Cannabinoids Potentiate Emotional Learning Plasticity in Neurons of the Medial Prefrontal Cortex through Basolateral Amygdala Inputs , 2006, The Journal of Neuroscience.

[19]  Masahiko Watanabe,et al.  Localization of diacylglycerol lipase-alpha around postsynaptic spine suggests close proximity between production site of an endocannabinoid, 2-arachidonoyl-glycerol, and presynaptic cannabinoid CB1 receptor. , 2006, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[20]  F. Conquet,et al.  Immunolocalization of the mGluR1b Splice Variant of the Metabotropic Glutamate Receptor 1 at Parallel Fiber‐Purkinje Cell Synapses in the Rat Cerebellar Cortex , 2000, Journal of neurochemistry.

[21]  David Robbe,et al.  Endogenous cannabinoids mediate long-term synaptic depression in the nucleus accumbens , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[22]  J. Sullivan,et al.  Cannabinoid receptors , 2002, Current Biology.

[23]  E. Fride Endocannabinoids in the central nervous system: from neuronal networks to behavior. , 2005, Current drug targets. CNS and neurological disorders.

[24]  D. Piomelli The endocannabinoid system: a drug discovery perspective. , 2005, Current opinion in investigational drugs.

[25]  Therese Garrick,et al.  Selective antagonist [3H]SR141716A binding to cannabinoid CB1 receptors is increased in the anterior cingulate cortex in schizophrenia , 2004, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[26]  P. Soubrié,et al.  Cannabinoids modulate synaptic strength and plasticity at glutamatergic synapses of rat prefrontal cortex pyramidal neurons. , 2000, Journal of neurophysiology.

[27]  Joseph E LeDoux,et al.  New vistas on amygdala networks in conditioned fear. , 2004, Journal of neurophysiology.

[28]  S. Charpier,et al.  In vivo induction of striatal long-term potentiation by low-frequency stimulation of the cerebral cortex , 1999, Neuroscience.

[29]  Tiziana Bisogno,et al.  Depolarization‐induced retrograde synaptic inhibition in the mouse cerebellar cortex is mediated by 2‐arachidonoylglycerol , 2006, The Journal of physiology.

[30]  David Robbe,et al.  A single in-vivo exposure to delta 9THC blocks endocannabinoid-mediated synaptic plasticity. , 2004, Nature neuroscience.

[31]  Wade G. Regehr,et al.  Endocannabinoids Control the Induction of Cerebellar LTD , 2005, Neuron.

[32]  Judit K. Makara,et al.  Selective inhibition of 2-AG hydrolysis enhances endocannabinoid signaling in hippocampus , 2005, Nature Neuroscience.

[33]  P. Soubrié,et al.  Direct and indirect interactions between cannabinoid CB1 receptor and group II metabotropic glutamate receptor signalling in layer V pyramidal neurons from the rat prefrontal cortex , 2003, The European journal of neuroscience.

[34]  Michael Davis,et al.  Enhancing Cannabinoid Neurotransmission Augments the Extinction of Conditioned Fear , 2005, Neuropsychopharmacology.

[35]  David Robbe,et al.  A single in-vivo exposure to Δ9THC blocks endocannabinoid-mediated synaptic plasticity , 2004, Nature Neuroscience.

[36]  Masahiko Watanabe,et al.  Subcellular Arrangement of Molecules for 2-Arachidonoyl-Glycerol-Mediated Retrograde Signaling and Its Physiological Contribution to Synaptic Modulation in the Striatum , 2007, The Journal of Neuroscience.

[37]  Ralitza Gueorguieva,et al.  Delta-9-tetrahydrocannabinol effects in schizophrenia: Implications for cognition, psychosis, and addiction , 2005, Biological Psychiatry.

[38]  W. Zieglgänsberger,et al.  The endogenous cannabinoid system controls extinction of aversive memories , 2002, Nature.

[39]  A. Grace,et al.  The roles of cannabinoid and dopamine receptor systems in neural emotional learning circuits: implications for schizophrenia and addiction , 2006, Cellular and Molecular Life Sciences CMLS.

[40]  T. Freund,et al.  Cannabinoid CB1 receptor dependent effects of the NMDA antagonist phencyclidine in the social withdrawal model of schizophrenia , 2005, Behavioural pharmacology.

[41]  A. Ghodse,et al.  Cannabis and psychotic illness , 1992, British Journal of Psychiatry.

[42]  R Lujan,et al.  Perisynaptic Location of Metabotropic Glutamate Receptors mGluR1 and mGluR5 on Dendrites and Dendritic Spines in the Rat Hippocampus , 1996, The European journal of neuroscience.

[43]  J. Bockaert,et al.  Complex interactions between mGluRs, intracellular Ca2+ stores and ion channels in neurons , 2000, Trends in Neurosciences.

[44]  A. Hoffman,et al.  Direct actions of cannabinoids on synaptic transmission in the nucleus accumbens: a comparison with opioids. , 2001, Journal of neurophysiology.

[45]  Ken Mackie,et al.  Cannabinoid receptors as therapeutic targets. , 2006, Annual review of pharmacology and toxicology.

[46]  R. Dingledine,et al.  Functional interactions between cannabinoid and metabotropic glutamate receptors in the central nervous system. , 2003, Current opinion in pharmacology.

[47]  Kristen K. Ade,et al.  Anandamide Regulates Postnatal Development of Long-Term Synaptic Plasticity in the Rat Dorsolateral Striatum , 2007, The Journal of Neuroscience.

[48]  P. Worley,et al.  A Single In Vivo Exposure to Cocaine Abolishes Endocannabinoid-Mediated Long-Term Depression in the Nucleus Accumbens , 2004, The Journal of Neuroscience.

[49]  Michael Davis,et al.  Systems-Level Reconsolidation Reengagement of the Hippocampus with Memory Reactivation , 2002, Neuron.

[50]  K. Mackie,et al.  Stimulation of Endocannabinoid Formation in Brain Slice Cultures through Activation of Group I Metabotropic Glutamate Receptors , 2005, Molecular Pharmacology.

[51]  R. Carelli,et al.  Nucleus accumbens cell firing during maintenance, extinction, and reinstatement of cocaine self-administration behavior in rats , 2000, Brain Research.

[52]  K. Mackie,et al.  Depolarization‐induced suppression of excitation in murine autaptic hippocampal neurones , 2005, The Journal of physiology.

[53]  H. Emrich,et al.  Elevated endogenous cannabinoids in schizophrenia. , 1999, Neuroreport.

[54]  T. Freund,et al.  Molecular Composition of the Endocannabinoid System at Glutamatergic Synapses , 2006, The Journal of Neuroscience.

[55]  Vivien Chevaleyre,et al.  Endocannabinoid-mediated synaptic plasticity in the CNS. , 2006, Annual review of neuroscience.

[56]  Joachim Klosterkötter,et al.  Cerebrospinal Anandamide Levels are Elevated in Acute Schizophrenia and are Inversely Correlated with Psychotic Symptoms , 2004, Neuropsychopharmacology.

[57]  祐輝 橋本谷,et al.  Phospholipase Cβ serves as a coincidence detector through its Ca[2+] dependency for triggering retrograde endocannabinoid signal , 2005 .

[58]  B. Dean,et al.  Studies on [3H]CP-55940 binding in the human central nervous system: regional specific changes in density of cannabinoid-1 receptors associated with schizophrenia and cannabis use , 2001, Neuroscience.

[59]  Hee-Sup Shin,et al.  Phospholipase Cβ Serves as a Coincidence Detector through Its Ca2+ Dependency for Triggering Retrograde Endocannabinoid Signal , 2005, Neuron.

[60]  D. Piomelli The molecular logic of endocannabinoid signalling , 2003, Nature Reviews Neuroscience.

[61]  D. Fortin,et al.  Differential effects of endocannabinoids on glutamatergic and GABAergic inputs to layer 5 pyramidal neurons. , 2006, Cerebral cortex.